Publications

Detailed Information

Association of Cytotoxic T Lymphocyte Antigen-4 Gene Polymorphisms and HLA Class II Alleles with the Development of Type 1 Diabetes in Korean Children and Adolescents

DC Field Value Language
dc.contributor.authorJung, Min Ho-
dc.contributor.authorYu, Jeesuk-
dc.contributor.authorShin, Choong Ho-
dc.contributor.authorSuh, Byung Kyu-
dc.contributor.authorLee, Byung Churl-
dc.contributor.authorYang, Sei Won-
dc.date.accessioned2012-06-12T04:05:15Z-
dc.date.available2012-06-12T04:05:15Z-
dc.date.issued2009-12-
dc.identifier.citationJOURNAL OF KOREAN MEDICAL SCIENCE; Vol.24 6; 1004-1009ko_KR
dc.identifier.issn1011-8934-
dc.identifier.urihttps://hdl.handle.net/10371/76987-
dc.description.abstractWe studied the association of cytotoxic T lymphocyte antigen-4 gene (CTLA4) polymorphisms with the development of type 1 diabetes (T1D) in Korean children and adolescents. A total of 176 Korean subjects (92 females and 84 males) with childhood-onset T1D were studied. The A/G polymorphism at position 49 in CTLA4 exon 1 and the C/T polymorphism at position -318 in the CTLA4 promoter were analyzed by PCR-RFLP methods. The genotype and allele frequencies of the CTLA4 polymorphisms in the T1D patients were not different from those in the controls. These polymorphisms were not associated with the clinical characteristics or the development of autoimmune thyroid disease in the T1D patients. The frequency of the A allele was significantly higher in the patients that did not have two out of the three susceptible HLA-DRB1 alleles, which were DRB1*0301, *0405 and *09012, compared to the controls (P<0.05). These results suggest that CTLA4 polymorphisms do not directly confer any susceptibility to T1D. However, a CTLA4-mediated susceptibility effect on the development of T1D might be significant in children and adolescents that do not have susceptible HLA class II alleles.ko_KR
dc.language.isoenko_KR
dc.publisherKOREAN ACAD MEDICAL SCIENCESko_KR
dc.subjectDiabetes Mellitus, Type 1ko_KR
dc.subjectHLAko_KR
dc.subjectGenesko_KR
dc.subjectCytotoxic T-lymphocyte Antigen 4ko_KR
dc.titleAssociation of Cytotoxic T Lymphocyte Antigen-4 Gene Polymorphisms and HLA Class II Alleles with the Development of Type 1 Diabetes in Korean Children and Adolescentsko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor정민호-
dc.contributor.AlternativeAuthor유지석-
dc.contributor.AlternativeAuthor신충호-
dc.contributor.AlternativeAuthor서병규-
dc.contributor.AlternativeAuthor양세원-
dc.contributor.AlternativeAuthor이병철-
dc.identifier.doi10.3346/jkms.2009.24.6.1004-
dc.citation.journaltitleJOURNAL OF KOREAN MEDICAL SCIENCE-
dc.description.citedreferenceSteck AK, 2005, DIABETES, V54, P2482-
dc.description.citedreferenceYu J, 2004, CLIN IMMUNOL, V113, P318, DOI 10.1016/j.clim.2004.08.009-
dc.description.citedreferenceUeda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621-
dc.description.citedreferenceMochizuki M, 2003, DIABETES CARE, V26, P843-
dc.description.citedreferenceField LL, 2002, DIABETOLOGIA, V45, P21-
dc.description.citedreferenceAbe T, 2001, DIABETIC MED, V18, P726-
dc.description.citedreferenceLigers A, 2001, GENES IMMUN, V2, P145-
dc.description.citedreferenceTakara M, 2000, DIABETES CARE, V23, P975-
dc.description.citedreferencePark YJ, 2000, THYROID, V10, P453-
dc.description.citedreferenceLee YJ, 2000, CLIN ENDOCRINOL, V52, P153-
dc.description.citedreferenceAbe T, 1999, DIABETES RES CLIN PR, V46, P169-
dc.description.citedreferencePark MH, 1999, HUM IMMUNOL, V60, P901-
dc.description.citedreferenceYanai K, 1999, CLIN EXP ALLERGY, V29, P29-
dc.description.citedreferenceGonzalez-Escribano MF, 1999, TISSUE ANTIGENS, V53, P296-
dc.description.citedreferenceBadenhoop K, 1999, EXP CLIN ENDOCR DIAB, V107, pS89-
dc.description.citedreferenceHeward JM, 1998, CLIN ENDOCRINOL, V49, P331-
dc.description.citedreferenceDonner H, 1998, DIABETES, V47, P1158-
dc.description.citedreferenceDjilali-Saiah I, 1998, DIABETES, V47, P125-
dc.description.citedreferenceYanagawa T, 1997, THYROID, V7, P843-
dc.description.citedreferenceMarron MP, 1997, HUM MOL GENET, V6, P1275-
dc.description.citedreferenceOwerbach D, 1997, DIABETES, V46, P1069-
dc.description.citedreferenceDonner H, 1997, J CLIN ENDOCR METAB, V82, P143-
dc.description.citedreferenceLane P, 1997, ANN NY ACAD SCI, V815, P392-
dc.description.citedreferenceDeichmann K, 1996, BIOCHEM BIOPH RES CO, V225, P817-
dc.description.citedreferenceNistico L, 1996, HUM MOL GENET, V5, P1075-
dc.description.citedreferenceWalunas TL, 1996, J EXP MED, V183, P2541-
dc.description.citedreferenceWALUNAS TL, 1994, IMMUNITY, V1, P405-
dc.description.citedreferenceBANNAI M, 1994, EUR J IMMUNOGENET, V21, P1-
dc.description.citedreferenceLUCASSEN AM, 1993, NAT GENET, V4, P305-
dc.description.citedreferenceEISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360-
dc.description.tc3-
Appears in Collections:
Files in This Item:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share